Form 4: Moderna's Chief Legal Officer Reports Stock Transactions

Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported the acquisition and disposal of company stock, including transactions related to restricted stock units.

Summary

• On September 6, 2024, Shannon Thyme Klinger, Moderna's Chief Legal Officer, engaged in transactions involving Moderna's common stock.
• These transactions included the conversion of 1,139 restricted stock units (RSUs) into common stock.
• Klinger also disposed of 551 shares of common stock on September 9, 2024, at a price of $73.5731 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Klinger directly owns 18,154 shares of Moderna common stock and 3,416 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Moderna.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The sale of shares to cover tax obligations is a standard practice and doesn't significantly affect the company's financial position.

Key Dates